Credit Suisse’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-423
Closed -$5K 4384
2022
Q2
$5K Buy
+423
New +$5K ﹤0.01% 3748
2022
Q1
Sell
-1,690
Closed -$40K 3638
2021
Q4
$40K Buy
+1,690
New +$40K ﹤0.01% 3573